Suppression de la libration de glucagon : GLP-1 drugs prevent the secretion of glucagon, particularly after meals
Although the role of liraglutide in alleviating hepatic fatty accumulation has been controversial, the idea is consistent with a recent reports that described that liraglutide combined with metformin significantly reduced body weight and intrahepatic lipid and visceral adipose tissue in patients with T2DM and NAFLD ( Clinically, liraglutide could reduce body weight and hepatic fatty accumulation ( The balance between fatty synthesis and lipolysis, which is catalyzed by related enzymes, determines fatty accumulation in the liver
Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects
Hsieh M-J, Liu H-T, Wang C-N, Huang H-Y, Lin Y, Ko Y-S, et al
Y., Kiriyama, K., Nakayama, H., & Kondo, A